Starling Oncology, Inc.

STLN

Exchange: Nasdaq
Industry: Services-Offices & Clinics of Doctors of Medicine
SEC CIK: 0001799191

SEC filings (opens in a new tab)

In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.

Other share classesDFPH STLNW

Superinvestors holding STLN, Q2 2026

See all superinvestors

No superinvestor reported holding STLN in Q2 2026.